AIDS-defining illnesses

NEW YORK, July 24 (Praxis Press) The introduction of highly active antiretroviral therapy (HAART) may have altered clinical patterns of HIV-related diseases. Mocroft and colleagues studied the incidence and types of AIDS-defining illnesses (ADIs) in European outpatient clinics between 1994 (pre-HAART) and 1998 (post-HAART). The incidence of ADIs declined significantly, and rates of ADIs were lower among patients receiving HAART for all CD4-cell strata. Non-Hodgkin lymphoma became one of the most

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 24 (Praxis Press) The introduction of highly active antiretroviral therapy (HAART) may have altered clinical patterns of HIV-related diseases. Mocroft and colleagues studied the incidence and types of AIDS-defining illnesses (ADIs) in European outpatient clinics between 1994 (pre-HAART) and 1998 (post-HAART). The incidence of ADIs declined significantly, and rates of ADIs were lower among patients receiving HAART for all CD4-cell strata. Non-Hodgkin lymphoma became one of the most common ADIs. Although HAART has decreased the incidence of ADIs, physicians are likely to encounter previously uncommon types of ADIs.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform